Rosacea continues to be a difficult dermatology issue to treat.
With no slam-dunk rosacea (ICD-10 code L71) treatments available, dermatologists welcome new therapies including topical ivermectin, said experts at recent meetings. Meanwhile, dermatologists are rethinking some older therapies while awaiting promising new options under development.
Standouts and struggles
No drug is Food and Drug Administration (FDA)-approved for ocular rosacea, said Julie C. Harper, M.D. She is a Birmingham, Ala.-based dermatologist in private practice who is affiliated with the University of Alabama at Birmingham. She is also president-elect of the American Acne & Rosacea Society (AARS). Dr. Harper spoke recently at the Skin Disease Education Foundation (SDEF)’s 12th Annual Women’s & Pediatric Dermatology Symposium, Newport Beach, Calif.
Read full article: Rosacea treatments | Dermatology Times
|Read Full Article: Rosacea treatments | Dermatology Times|